Kate Woda, IO Combinations 360° Conference Director, gives a 7 minute overview on what you can expect at the 5th annual IO Combinations 360° conference taking place October 1-2 virtually.

2020 Key Topics:

Discovery / Preclinical Science
Bispecifics
Translational Science & Biomarkers
Next Generation Cell Therapy
Clinical Developments
Operationalizing Combinations
Business Aspects
Emerging Technologies

Keynotes Include:

Ronald Germain, MD, PhD, National Institutes of Health
Steve Hamilton, Melanoma Cancer Survivor
Edward Tenthoff, Piper Sandler & Co.

2020 Strategic Leadership:

Dan Chen, MD, PhD, IGM Biosciences
Axel Hoos, MD, PhD, GSK
Alexandra Snyder, MD, Merck Research Labs
Omid Hamid, MD, The Angeles Clinic and Research Institute
Raluca Verona, PhD, Janssen R&D
James Gulley, MD, PhD, National Cancer Institute, NIH
Theresa LaVallee, PhD, Parker Institute for Cancer Immunotherapy
Roy Baynes, MD, PhD, Merck Research Labs
Michael Kalos, PhD, ArsenalBio

Learn more about the upcoming IO Combinations 360° virtual conference at www.iocombinations360.com

IO Combinations 360° Overview in 7 Minutes

Share

Embed